RE:RE:RE:RE:Just asking for numbers.
IBRX doesn't seem to be selling much anktiva based on last financials. So you could argue that urologists are saying that that medication doesn't meet their needs. Plus anktiva needs BCG which is in short supply to start with.
Adstiladrin is made by private company with no financials out. So hard to guess the sales. But I doubt that they are that great judging but DOR for the drug.
So, there is an unmet need in reality but perhaps not on paper.